Genetic and clinical characteristics of head and neck paragangliomas in a chinese population

Laryngoscope

Volumn 122, Issue 8, 2012, Pages 1761-1766

  Zheng, Xiangqian ^a   Wei, Songfeng ^a   Yu, Yang ^a   Xia, Tingting ^a   Zhao, Jing ^a   Gao, Songyuan ^b   Li, Yigong ^a   Gao, Ming ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

familial paragangliomas; Head and neck; Level of Evidence: 4; malignancy; paragangliomas; SDH gene mutation

Indexed keywords

SUCCINATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURGERY; CAROTID ARTERY BIFURCATION; CHINESE; CLINICAL FEATURE; DNA SEQUENCE; EXON; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEAD AND NECK PARAGANGLIOMA; HEAD AND NECK TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARAGANGLIOMA; PRIORITY JOURNAL; RARE DISEASE; RETROSPECTIVE STUDY; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GERM-LINE MUTATION; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PARAGANGLIOMA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; SUCCINATE DEHYDROGENASE; YOUNG ADULT;

EID: 84864402921     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23360     Document Type: Article

References (32)

1. Stenstrom G, Svardsudd K,. Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data. Acta Med Scand 1986; 220: 225-232. (Pubitemid 17168529)
2. Parry DM, Li FP, Strong LC, et al. Carotid body tumors in humans: genetics and epidemiology. J Natl Cancer Inst 1982; 68: 573-578. (Pubitemid 12078840)
3. Milunsky JM, Maher TA, Michels VV, et al. Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. Am J Med Genet 2001; 100: 311-314. (Pubitemid 32382404)
4. Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006; 91: 827-836. (Pubitemid 43357746)
5. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001; 69: 49-54. (Pubitemid 32614017)
6. Hensen EF, van Duinen N, Jansen JC, et al. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands. Clin Genet 2012; 81: 284-288.
7. Peczkowska M, Cascon A, Prejbisz A,. et al. Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation. Nat Clin Pract Endocrinol Metab 2008; 4: 111-115. (Pubitemid 351156901)
8. Hermsen MA, Sevilla MA, Llorente JL, et al. Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management. Cell Oncol 2010; 32: 275-283.
9. Neumann HP, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004; 292: 943-951. (Pubitemid 39097204)
10. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 2003; 63: 5615-5621. (Pubitemid 37139886)
11. Bayley JP, Devilee P, Taschner PE,. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet 2005; 6: 39.
12. Timmers HJ, Pacak K, Bertherat J, et al. Mutations associated with succinate dehydrogenase D-related malignant paragangliomas. Clin Endocrinol 2008; 68: 561-566. (Pubitemid 351388709)
13. Krijger R, van Nederveen FH, Korpershoek E, et al. New developments in the detection of the clinical behavior of pheochromocytomas and paragangliomas. Endocr Pathol 2006; 17: 137-142.
14. Burnichon N, Rohmer V, Amar L, et al. PGL.NET network. J Clin Endocrinol Metab 2009; 94: 2817-2827.
15. Chapman DB, Lippert D, Geer CP, et al. Clinical, histopathologic, and radiographic indicators of malignancy in head and neck paragangliomas. Otolaryngol Head Neck Surg 2010; 143: 531-537.
16. Mills SE, Gaffey MJ, Frierson HF Jr,. Tumors of the upper aerodigestive tract and ear. In: Atlas of Tumor Pathology. Series 3, Fasc. 26. Washington, DC: Armed Forces Institute of Pathology; 2000.
17. Barnes L, Everson JW, Reichart P, et al. In:, Kleihues P, Cavanee WK, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC Press; 2005.
18. Lee JH, Barich F, Karnell LH, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer 2002: 94: 730-737. (Pubitemid 34132302)
19. Havekes B, Corssmit EP, Jansen JC, et al. Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. J Clin Endocrinol Metab 2007; 92: 1245-1248. (Pubitemid 46556393)
20. Brouwers FM, Eisenhofer G, Tao JJ, et al. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab 2006; 91: 4505-4509. (Pubitemid 44833431)
21. Khorram Manesh A, Ahlman H, Nilsson O, et al. Long term outcome of a large series of patients surgically treated for pheochromocytoma. J Intern Med 2005; 258: 55-66. (Pubitemid 40904933)
22. Mhatre AN, Li Y, Feng L, Gasperin A, Lalwani AK,. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas. Clin Genet 2004; 66: 461-466. (Pubitemid 39429743)
23. Favier J, Briere JJ, Strompf L, et al. Hereditary paraganglioma pheochromocytoma and inherited succinate dehydrogenase deficiency. Horm Res 2005; 63: 171-179. (Pubitemid 40875058)
24. Neumann HP, Erlic Z, Boedeker CC, et al. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res 2009; 69: 3650-3656.
25. Baysal BE, Ferrell RE, Willett Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000; 287: 848-851. (Pubitemid 30084326)
26. Hes FJ, Weiss MM, Woortman SA, et al. Low penetrance of a SDHB mutation in a large Dutch paraganglioma family. BMC Med Genet 2010; 11: 92.
27. Gill AJ, Benn DE, Chou A, et al. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum Pathol 2010; 41: 805-814.
28. Korpershoek E, Petri BJ, van Nederveen FH, et al. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma. Endocr Relat Cancer 2007; 14: 453-462. (Pubitemid 47242643)
29. Cascon A, Pita G, Burnichon N, et al. Genetics of pheochromocytoma and paraganglioma in Spanish patients. J Clin Endocrinol Metab 2009; 94: 1701-1705.
30. Ricketts CJ, Forman JR, Rattenberry E, et al. Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 2010; 31: 41-51.
31. Lee SC, Chionh SB, Chong SM, Taschner PE,. Hereditary paraganglioma due to the SDHD M1I mutation in a second Chinese family: a founder effect? Laryngoscope 2003; 113: 1055-1058. (Pubitemid 36676606)
32. Shamblin WR, ReMine WH, Sheps SG, et al. Carotid body tumor (chemodectoma): Clinicopathologic analysis of ninety cases. Am J Surg 1971; 122: 732-739.